Skip to content
Ships from Provo, Utah · We ship to CanadaAll Prices are in US DollarsFor Research Use Only. Not for Human Consumption.

Why might a specialist consider FSH after an hCG response?

A response to one reproductive hormone does not establish that every part of sperm production has recovered. That is the central reason “my testosterone improved” and “why discuss FSH?” can both be reasonable statements in the same clinical conversation.

In a single-arm trial in men with hypogonadotropic hypogonadism, some participants remained azoospermic after hCG treatment even though their testosterone had normalized. Eighteen entered a combination phase involving an FSH analogue, and 14 reached the trial's sperm-concentration endpoint. The study concerns a defined hormone-deficiency population and a specific prescription-study intervention.

A sequence in a trial is not a home protocol

The informative part is the separation of outcomes. Testosterone normalization did not itself demonstrate sperm production. The later result suggests why specialists investigate more than one part of the reproductive pathway.

It does not show that everyone taking hCG should add FSH, hMG or another medicine. Nor does it prove that those products are interchangeable. The study lacked a parallel randomized comparison for that combination phase, and participants were selected according to a particular diagnosis and response.

For a reader, the better question is not “what should I add?” but “what explains the remaining problem?” The answer could change the interpretation of a hormone result, the relevance of a study population and the purpose of any further testing. A treatment plan assembled by matching names from unrelated papers skips those distinctions.

Ask the treating specialist to explain the proposed target, the evidence in the actual diagnosis and the outcome that would justify continuing or reconsidering a plan. Include the full medication list so overlapping treatments are visible.

This paper supports a focused evidence lesson: reproductive endpoints can separate even when one hormone measurement improves. It does not validate a self-directed stack, establish a universal fertility sequence or authenticate an online catalog preparation.

Information you can check.

Lab reports, store policies, and support — all in one place.

Card options
Visa Mastercard
Available payment options are shown at checkout.
HTTPS connection

For research use only.
Not for human consumption.